Top 50 Health Care Startup Investors in Hong Kong (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Gobi Partners
VC Fund
|
5 | China, Malaysia, Hong Kong | Series A, Seed, Series B | E-Commerce, Financial Services, Internet | $800k–$37M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
4 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
Apricot Capital
VC Fund
|
3 | China, United States, Hong Kong | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $3M–$58M |
|
5Y Capital
VC Fund
|
3 | China, United States, India | Series A, Series B, Series C | Artificial Intelligence, Biotechnology, Software | $5M–$400M |
|
Cowin Venture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Angel, Series B | Health Care, Medical, Biotechnology | $425k–$257M |
|
Novel Tycoon
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food | $1.3M–$1.3M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
BioVenture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.9M–$73M |
|
Vectr
VC Fund
|
2 | United States, Hong Kong, Singapore | Seed, Series A, Series B | FinTech, Financial Services, Artificial Intelligence | $547k–$70M |
|
Chartwell Ventures
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food | $1.3M–$1.3M |
|
FHB Ventures
VC Fund
|
2 | Hong Kong, United States | Seed, Series A, Series B | Medical, Agriculture, Biotechnology | |
|
Simmons Foods
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
PT Medion
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
HSG
VC Fund
|
2 | China, United States, Australia | Series B, Series A, Seed | Artificial Intelligence, Biotechnology, Software | $2M–$293M |
|
Med-Fine Capital
VC Fund
|
2 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.8M–$60M |
|
Arkansas Development Finance Authority
VC Fund
|
2 | United States, Hong Kong | Seed, Pre-Seed | Medical, Biotechnology, Fashion | |
|
FJ Labs
VC Fund
|
2 | United States, Brazil, United Kingdom | Seed, Series A, Series B | Software, E-Commerce, Financial Services | $1.4M–$65M |
|
Seveno Capital
VC Fund
|
2 | Japan, Hong Kong, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Sensor, Travel, Wearables | |
|
FEBE Ventures
VC Fund
|
2 | Singapore, Vietnam, Thailand | Seed, Series A, Pre-Seed | FinTech, Financial Services, Software | $780k–$30M |
|
Particle Accelerator Limited (ParticleX)
VC Fund
|
2 | Hong Kong, United States, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Information Technology, Software | $1M–$6.9M |
|
Picus Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $549k–$33M |
|
Qiming Venture Partners
VC Fund
|
2 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
Groove Capital
VC Fund
|
2 | United States, Hong Kong, Mauritius | Seed, Pre-Seed, Series A | Software, Health Care, Information Technology | $120k–$3.3M |
|
Lisa-Marie Tse
Angel
|
2 | Hong Kong | Seed | Nutrition, Organic Food | $1.3M–$1.3M |
|
Bold Capital Partners
VC Fund
|
2 | United States, Hong Kong, India | Series A, Series B, Seed | Health Care, Biotechnology, Software | $2M–$58M |
|
Whist Subholdings
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
Hony Capital
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B | E-Commerce, Biotechnology, Food and Beverage | $3.8M–$390M |
|
Joe Zhu Pan
Angel
|
1 | Hong Kong | Pre-Seed | Software, Lifestyle, Mental Health | |
|
SFUND
VC Fund
|
1 | China, Hong Kong, United States | Angel, Series A, Post-IPO Equity | Manufacturing, Agriculture, Medical Device | |
|
Wistron Corporation
VC Fund
|
1 | United States, Taiwan, Hong Kong | Series B, Seed, Series A | Software, Artificial Intelligence, Machine Learning | |
|
FutureX Capital
VC Fund
|
1 | China, United States, Hong Kong | Seed, Series B, Series A | Artificial Intelligence, Software, Health Care | |
|
Alon Capital Ltd
VC Fund
|
1 | Hong Kong | Series A | Biopharma, Life Science, Biotechnology | |
|
Shanghai Biomedical Industrial Equity Investment Fund
VC Fund
|
1 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | |
|
Hillhouse Investment
VC Fund
|
1 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Justin Kan
Angel
|
1 | United States, Nigeria, India | Seed, Series A, Pre-Seed | Software, Financial Services, SaaS | $808k–$23M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
StartUp Health
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Formic Ventures
VC Fund
|
1 | United States, United Kingdom, Hong Kong | Seed, Series A | Biotechnology, Health Care, Biopharma | $1.3M–$61M |
|
Emerging Technology Partners
VC Fund
|
1 | China, United States, Hong Kong | Series A, Series B | Biotechnology, Medical, Health Care | $3.4M–$9.9M |
|
Proxima Ventures Ltd
VC Fund
|
1 | China, United States, Israel | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $213k–$150M |
|
Gobi Partners GBA
VC Fund
|
1 | Hong Kong, China | Seed, Angel, Series A | Biotechnology, Medical, Hospitality | |
|
AEF Greater Bay Area Fund
VC Fund
|
1 | Hong Kong, China, Macao | Seed, Series A, Series B | Biotechnology, Sports, Sustainability | |
|
Pavilion Capital
VC Fund
|
1 | United States, Japan, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Information Technology | |
|
Alven
VC Fund
|
1 | France, United States, Germany | Series A, Seed, Series B | Software, Internet, Artificial Intelligence | |
|
Apis Partners
VC Fund
|
1 | India, South Africa, Hong Kong | Private Equity, Series B | Financial Services, Payments, FinTech | |
|
GrowthX
VC Fund
|
1 | United States, Canada, Italy | Seed, Convertible Note, Angel | Software, SaaS, Machine Learning | |
|
Pierre Bolduc
Angel
|
1 | Hong Kong | Pre-Seed | Software, Lifestyle, Mental Health | |
|
Hillhouse Ventures
VC Fund
|
1 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | |
|
WuXi AppTec
VC Fund
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | |
|
A-Level Capital
VC Fund
|
1 | United States, Hong Kong | Seed, Series A | Health Care, Medical, SaaS | $100k–$6M |
| Access all 236 investors in Hong Kong Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Internet
- Stage:Series A, Seed, Series B
- Geography: China, Malaysia, Hong Kong
Investor stats
- Total investments: 237
- Round size: Seed $800k–$7M; Series A $1.5M–$20M; Series B $5.5M–$37M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $1.3B in 2023
Portfolio highlights
- Carsome — Carsome is an online used car platform that provides efficient car selling services to individuals and entities. Through its online bidding portal, customers are able to sell their vehicles directly to dealers. Carsome facilitates the entire car selling process from inspection to valuation, bidding, and payment as well as logistics needs, allowingthe customers to sell their cars.It was founded in 2015 and headquartered in Malaysia, the company has expanded to Indonesia, Thailand, and Singapore.
- Deliveree Logistics — Feb 1, 2022 - Welcome to the revolution. With the largest truck fleet in Southeast Asia, we provide businesses with first, mid, and last mile transportation.
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 44
- Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$58M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
- Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
5Y Capital is a firm engaged in providing early-stage venture investments. It was formerly known as Morningside Venture Capital. The investment firm manages USD 5bn in dual-currency funds in USD and RMB, backed by world-renowned sovereign wealth funds, family offices, fund of funds, university endowments, pensions, and foundations. It is aninvestment firm of Morningside Group.It was headquartered in Xuhui, Shanghai, China in 2008 by Ken Shi and Richard Liu.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 235
- Round size: Series A $5M–$102M; Series B $10M–$227M; Series C $30M–$400M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- X-EPIC — X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.
- Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.
- ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Angel, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 97
- Round size: Angel $425k–$1.4M; Series A $1.4M–$28M; Series B $2.8M–$257M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Furong Biotech — Furong Bio is a developer of innovative tumor immunology drugs.
- Amador Bioscience — At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
- BioTroy Therapeutics — BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Novel Tycoon
Show more...Investment focus
- Industry: Nutrition, Organic Food
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Allklear is a Hong Kong food tech startup combining nature and technology.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 165
- Round size: Seed $7.1M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
- Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong, Singapore
Investor stats
- Total investments: 74
- Round size: Seed $547k–$5.3M; Series A $1M–$37M; Series B $12M–$70M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Chartwell Ventures is an investment firm.
Show more...Investment focus
- Industry: Nutrition, Organic Food
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Allklear is a Hong Kong food tech startup combining nature and technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FHB Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
PT Medion is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Series B, Series A, Seed
- Geography: China, United States, Australia
Investor stats
- Total investments: 197
- Round size: Seed $2M–$42M; Series A $14M–$143M; Series B $12M–$293M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- SceneRay — Sceneray Co. Ltd, located at Singapore Industrial Park in Suzhou China, is a medical device company dedicated to the design, development, and distribution of neuromodulation devices. The core team of Sceneray is made up by experts with deep China and overseas experiences in neuromodulation device development, manufacturing, and marketing. Scenerayholds many patents and keeps on exploring the frontiers in neuromodulation. Being an international high-tech medical and competitive company, Sceneray is dedicated to providing patients with high-quality and efficacious treatments.
- DentaLink China — Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.
- Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 78
- Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $69M in 2019
Portfolio highlights
- Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!
Show more...Investment focus
- Industry: Medical, Biotechnology, Fashion
- Stage:Seed, Pre-Seed
- Geography: United States, Hong Kong
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Ascendant Dx — Choose An Online Slot Game
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
- BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
FJ Labs is a stage-agnostic investment firm that focuses on marketplaces and consumer facing startups.
Show more...Investment focus
- Industry: Software, E-Commerce, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, United Kingdom
Investor stats
- Total investments: 897
- Round size: Seed $1.4M–$10M; Series A $4.4M–$30M; Series B $12M–$65M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $5.5M in 2016
Portfolio highlights
- Fresha — Find the best salons and spa in your area with Fresha salon booking software. Book now!
- Lastro — Lastro is an all-in-one real estate management platform with integrated payments that simplifies managing rental properties. It helps landlords streamline workflows by organizing lease contract information in a cloud-based system, automating rent charging processes, monitoring tenant obligations and generating customized reports.
- POC Pharma — POC Pharma is a SaaS company helping the stakeholders in the Pharmacy Channel to digitally manage their go to market strategy.
Seveno Capital is a venture capital fund backing early and growth-stage ventures with the holistic potential to extend human healthspan. Seveno Capital specialises in providing strategic capital and expert guidance to visionary entrepreneurs around the world.Seveno Capital is dedicated to seeding and nurturing the growth of businesses that aremaking a positive impact, rooted in a deep understanding of the interplay between fitness, holistic wellness and longevity solutions in extending the human healthspan.Seveno Capital is committed to fostering innovation and scalability by providing strategic capital and expertise to accelerate the growth of purpose-driven ventures whilst also ensuring that financial returns are intrinsically linked to positive social outcomes. Seveno Capital is backed by Allen Law, an investor with 20 years of global leadership in hospitality, wellness, fitness and longevity. Allen Law is also Founder at Park Hotel Group, Co-Founder at MOVE [REPEAT] and is Chairman at REVL Training.
Show more...Investment focus
- Industry: Sensor, Travel, Wearables
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Japan, Hong Kong, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- A Cabin Company — A cabin company is a company that creates and operates small, attractively built cottages located in rural or semi-rural locations. These cabins are designed to promote human health and wellness by providing access to healing natural environments.
- PointFit Technology — PointFit Technology develops non-invasive wearable devices that monitor health through sweat biomarkers. They provide real-time, continuous health insights, making them useful for both wellness and potential medical applications. Their aim is to offer a seamless and convenient way to track health metrics without the need for invasive procedures.They are positioned within the sporting goods industry that focuses on the future of sports wearables.
- Longevity Technology — Longevity Technology is a daily news and insights on research, investments and technologies that extend life.
FEBE Ventures (“For Entrepreneurs, By Entrepreneurs”) is an early stage Venture Capital fund supporting outstanding entrepreneurs in Vietnam & Southeast Asia. The fund is managed by 4 entrepreneurs with +28 years of experience building and scaling companies in Vietnam & Southeast Asia, and investing in tech startups in Asia, Europe andSouth America. We apply a value-added approach, backing the best founders and offering our local business expertise, operational know-how, and global network.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Singapore, Vietnam, Thailand
Investor stats
- Total investments: 51
- Round size: Seed $1.5M–$4.9M; Pre-Seed $780k–$2.4M; Series A $6M–$30M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $75M in 2023
Portfolio highlights
- HD — Guiding patients to the right next step and connecting them to real-world care with AI. Trusted by 500k+ patients and 3k+ providers.
- Prósperos — Founded in 2023 by Vinay Pai and Salvador Chavez, Prósperos is delivering an innovative financial platform that allows millions of Latinos to manage their finances while taking care of their family in the USA and Latin America.The Prósperos platform provides two bank accounts and two cards– one for the account holder in the USA and one for theirfamily in Mexico, and soon Central and South America. With Prósperos, customers can say goodbye to slow and costly money-transfer solutions, and their families no longer need to wait in line to pick up cash. Within seconds, funds are available to family members in Latin America.
- Nano Technologies — VUI provides Flexible Payroll (EWA) solutions, income statistics, and employee financial management education through a technology platform.
Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Hong Kong, United States, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$5.5M; Series A $1M–$6.9M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
- MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
- Crown Digital — Crown Digital harnesses the future-ready power of robotics and Artificial Intelligence to open doors with cutting-edge solutions for the not-so-distant future.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 341
- Round size: Seed $1.5M–$11M; Pre-Seed $549k–$4.5M; Series A $3.7M–$33M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Solarize — Solarize provides SaaS for energy production, distribution and billing for commercial microgrids.
- D2X Group — Trade digital asset options and futures on the EU-regulated market infrastructure for institutions.
- Lightbase — Plan, align, and ship complex projects faster. Lightbase maps your architecture across services and hands agents the full context to make safe, coordinated changes.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 740
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Plum — Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
- Bytelumio — Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
- Guangjing Energy — Guangjing Energy is a perovskite solar cell module developer, dedicated to the R&D of long-life large-area perovskite solar cell modules.
Groove Capital is a new investment firm targeting early-stage companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Hong Kong, Mauritius
Investor stats
- Total investments: 131
- Round size: Seed $405k–$3.3M; Pre-Seed $120k–$2M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- BetterYou — Transform your wellness journey with BetterYou, the personalized productivity coach that helps you achieve your goals efficiently and effectively.
- Carbon Origins — Carbon Origins is a robotics company on a mission to Make Robots Commonplace.
- Character — The next-gen home improvement destination.
Lisa-Marie Tse is a Chief Brand Officer and Founder of Allklear.
Show more...Investment focus
- Industry: Nutrition, Organic Food
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Allklear is a Hong Kong food tech startup combining nature and technology.
A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Hong Kong, India
Investor stats
- Total investments: 126
- Round size: Seed $2M–$15M; Series A $6M–$40M; Series B $15M–$58M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- KeyCare — KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.
- Liquid AI — Liquid AI is an MIT spin-off with a presence in Boston, MA, and Palo Alto, CA. Our mission is to build state-of-the-art, general-purpose AI systems from first principles and deploy capable, efficient, highly aligned, and trustworthy AI for all.
- Gallant — Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.The company offers services that include retrieving valuable stem and regenerative cells, enabling pet owners to preserve their pet's young stem, and use them in treatment when necessary.Gallant Pet was established in 2018 by Aaron Hirschhorn andis headquartered in San Diego, California.
Whist Subholdings is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Founded in 2003, Hony Capital is a pioneer in China’s home grown private equity industry. Sponsored by Legend Holdings, a leading Chinese conglomerate, Hony has blazed the trail in formulating private equity investment strategies suitable for Chinese conditions by combining a deep understanding of local environment and people with global resourcesand international best practices. Today, with over USD 6.8 billion in assets under management across 7 funds and investments in over 60 companies, Hony is a leading China-focused private equity firm.Adhering to the “value creation” investment philosophy, Hony partners with managers and entrepreneurs to build their businesses into sustainable leaders in respective industries. Hony focuses on sectors where it has developed expertise: pharmaceuticals and healthcare, consumer & retail, media & entertainment, financial services, construction materials, machinery, and alternative energy & resources
Show more...Investment focus
- Industry: E-Commerce, Biotechnology, Food and Beverage
- Stage:Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 68
- Round size: Series A $6.4M–$390M; Series B $3.8M–$76M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.
- LaNova Medicines — LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
- Zhongguancun Shuimu Medical Technology — Shuimu Medical is a third-party professional medical device inspection and testing institution.
Joe Zhu Pan
Show more...Investment focus
- Industry: Software, Lifestyle, Mental Health
- Stage:Pre-Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- EthicalAI — EthicalAI is a global initiative committed to reshaping the future of artificial intelligence with a foundation in ethics, privacy, and innovation. Its mission is to ensure AI technologies serve humanity responsibly and transparently, addressing critical issues like data security, intellectual property, and creator rights.EthicalAI drivesprogress through a distributed network of R&D teams and global offices, uniting experts from diverse fields to develop cutting-edge, user-centric solutions. By championing ethical practices and fostering collaboration, EthicalAI empowers individuals and organizations to harness the transformative potential of AI for societal benefit while maintaining trust and integrity.
SFUND is a social investment and financing platform specially established for social investment and strengthening the status of regional financial centers.
Show more...Investment focus
- Industry: Manufacturing, Agriculture, Medical Device
- Stage:Angel, Series A, Post-IPO Equity
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 32
- Lead/follow: no public data
Portfolio highlights
- Mymro — Mymro engages in providing digital supply chain procurement solutions.
- Lehe Food — Guangdong Lehe Food Co., Ltd. now has more than a dozen distribution centers, relying on the management headquarters in Guangzhou to provide standardized and professional management to the companies that are constantly replicating and expanding throughout the country through reasonable shareholding structure and standardized corporate governance.Services; its industries cover farm operation management, agricultural planting and breeding, agricultural product processing and distribution, catering management, high-end agricultural products online mall, agricultural information technology consulting, etc. The business area has basically covered Guangdong, Hainan, Yunnan and Shanghai. And accelerate the expansion to other key areas of the country.
- Juwan Technology — Juwan Technology Research Institute is the first in-house incubation technology innovation company of GAC Group.
Wistron Corporation is a technology service provider supplying innovative.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series B, Seed, Series A
- Geography: United States, Taiwan, Hong Kong
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- iKala — iKala's mission is to enable AI competencies of our enterprise customers, to increase their customer acquisition capability and customer lifetime value.
- GMI Cloud — GMI Cloud is a business of empowering the world's best ideas. Which provide businesses all over the globe with unmatched cloud access to top-tier GPUs like the NVIDIA H100 and streamlined software platform for integration, virtualization, and deployment.
- Princeton NuEnergy — Princeton NuEnergy is a clean-tech startup focused on the direct recycling of lithium-ion batteries from electric vehicles and consumer electronics. Its patented Direct Battery Recycling technology to produce high-quality and high value-added cathode active materials with low operating cost from spent lithium-ion batteries and delivers sustainableenergy and environmental solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FutureX Capital is an investment firm.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series B, Series A
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Gewu Technology — Gewu Technology is an innovative IoT technology company, likely plays a role in building a future smart home by developing and integrating smart hardware and software solution
- Lymow Technology — Lymow Technology is a manufacturer of lawn mowing robots.
- Touchable Future — Touchable Future is an intelligent hardware company focusing on interactive innovation, committed to analyzing and customizing entertaining and emotional experiences for adults.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 52
- Lead/follow: no public data
Portfolio highlights
- Editact — Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.
- Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
- NeuShen Therapeutics — NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Justin Kan is the Co-Founder of Stash. He previously worked at Atrium as a CEO. Justin Kan attended Yale University.
Show more...Investment focus
- Industry: Software, Financial Services, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Nigeria, India
Investor stats
- Total investments: 105
- Round size: Seed $1.5M–$6.7M; Pre-Seed $808k–$20M; Series A $7.5M–$23M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Blue — An Operating System for your Personal Health. Join the waitlist here.
- FLORA — FLORA is an applied AI HCI company building creative tools.
- Thrive Protocol — Thrive Protocol's vision is to maximize value creation for all people and communities.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 227
- Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Biopharma
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Hong Kong
Investor stats
- Total investments: 39
- Round size: Seed $1.3M–$12M; Series A $17M–$61M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 10
- Round size: Series B $3.4M–$9.9M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.
- Precision Autoimmune Therapeutics — Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: China, United States, Israel
Investor stats
- Total investments: 20
- Round size: Seed $750k–$4.5M; Series A $213k–$10M; Series B $10M–$150M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Gobi Partners: Leading Venture Capital in Asia. Accelerating Innovation, Fueling Success.
Show more...Investment focus
- Industry: Biotechnology, Medical, Hospitality
- Stage:Seed, Angel, Series A
- Geography: Hong Kong, China
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- GenEditBio — GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
- Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
- Guoke Ling Fiber — Guoke Ling Fiber focuses on technological research and industrialization of key materials for hydrogen fuel cells. Guoke offers carbon fiber base paper and carbon paper production lines.
AEF Greater Bay Area Fund is an investment fund.
Show more...Investment focus
- Industry: Biotechnology, Sports, Sustainability
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, China, Macao
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- ORCA-TECH — ORCA-TECH is a manufacturer of self-driving boat.
- SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
- Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
Provides growth equity to market leading companies in the United States and China
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, Japan, Singapore
Investor stats
- Total investments: 73
- Lead/follow: no public data
Portfolio highlights
- Rebellions — On a Mission to Empower Efficient and Scalable Generative AI
- Lhoopa — Making homeownership achievable for every Filipino family.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Alven is an independent early-stage venture capital firm that backs European category-defining startups with global reach starting at Series A or Seed stage
Show more...Investment focus
- Industry: Software, Internet, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 201
- Lead/follow: no public data
Portfolio highlights
- Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
- Skynopy — Skynopy offers an end-to-end connectivity solution for satellite operators to communicate with their satellites in Low-Earth Orbit.
- Skarlett — Skarlett is a real estate firm that provides purchasing power to the old age people by releasing the wealth blocked in real estate assets.
Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.
Show more...Investment focus
- Industry: Financial Services, Payments, FinTech
- Stage:Private Equity, Series B
- Geography: India, South Africa, Hong Kong
Investor stats
- Total investments: 42
- Lead/follow: no public data
Portfolio highlights
- KPay — KPay is a financial technology company that provides comprehensive payment collection solutions to SME merchants. It helps businesses streamline management processes and improve customer retention, business efficiency, and flexibility. KPay creates a more intuitive approach to running a business that enables merchants to reach their maximumpotential.
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- MNT-Halan — MNT-Halan is a microfinance lending and payments company.
First we help. Then we invest. Together we rise.
Show more...Investment focus
- Industry: Software, SaaS, Machine Learning
- Stage:Seed, Convertible Note, Angel
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 50
- Lead/follow: no public data
Portfolio highlights
- FleetPanda — 100% cloud and smart phone based. No hardware, No install required. Try for 2 weeks before you buy.
- HouseKeys — HouseKeys is a for-profit / nonprofit hybrid focused on the economic empowerment of income-eligible households seeking affordable housing options for rent or purchase in high-cost metro and rural areas. We began in 2015, serving as a 3rd-Party contracted Housing Department for Bay Area cities who needed staffing and systems to run theirhousing programs. The next iteration of our company will be to grow our database of low-to-moderate income households and connect them with housing opportunities in California, nationwide, and urbanizing metro areas throughout the world.
- Aerotrax — The Next Generation of Aircraft Maintenance Software. Aerotrax is an enterprise software company focused on digitally tracking the lifecycle of every aircraft, part, and component.
Pierre Bolduc
Show more...Investment focus
- Industry: Software, Lifestyle, Mental Health
- Stage:Pre-Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- EthicalAI — EthicalAI is a global initiative committed to reshaping the future of artificial intelligence with a foundation in ethics, privacy, and innovation. Its mission is to ensure AI technologies serve humanity responsibly and transparently, addressing critical issues like data security, intellectual property, and creator rights.EthicalAI drivesprogress through a distributed network of R&D teams and global offices, uniting experts from diverse fields to develop cutting-edge, user-centric solutions. By championing ethical practices and fostering collaboration, EthicalAI empowers individuals and organizations to harness the transformative potential of AI for societal benefit while maintaining trust and integrity.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 69
- Lead/follow: no public data
Portfolio highlights
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
- Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Founded in 2015, A-Level Capital is a student-run venture capital firm that aims to empower Johns Hopkins University's entrepreneurial community through funding and support.
Show more...Investment focus
- Industry: Health Care, Medical, SaaS
- Stage:Seed, Series A
- Geography: United States, Hong Kong
Investor stats
- Total investments: 18
- Round size: Seed $100k–$4.6M; Series A $2.8M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Order — Modernize your procure-to-pay process with Order.co. Automate purchasing & payments to help your business save time, save money, and gain clarity.
- Siren Care — Siren Socks help reduce the risk of foot ulcers for patients with diabetes through the early detection of potential injuries.
- Leap AI — Humanize AI-generated text to read naturally and pass the major detectors. Free detection, no signup.
Health Care Investor funding in Hong Kong at a glance
Stats across 117 deals from 236 investors.
Access all 236 investors in Hong Kong Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 236 investors investing in Hong Kong Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!